{"schema_version":"1","generated_at":"2026-11-13T01:27:18.756Z","data_as_of":null,"url":"https://www.findmykol.com/kol/andrew-frankart","json_url":"https://www.findmykol.com/kol/andrew-frankart/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"andrew-frankart","name":"Andrew Frankart","specialty":"Radiation Oncology","specialty_raw":"Radiation Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Cincinnati Children's Hospital Medical Center","institution_url":"https://www.findmykol.com/institution/cincinnati-children-s-hospital-medical-center","city":"Cincinnati","state":"OH","region":{"label":"Midwest","url":"https://www.findmykol.com/region/midwest"}},"identifiers":{"npi":"1558867374","orcid":"0000-0002-1220-6511","openalex":"A5032195937"},"summary":"Andrew Frankart is an Oncology physician affiliated with Cincinnati Children's Hospital Medical Center. OpenAlex indexes 38 publications with 238 citations (h-index 7).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":38,"cited_by_count":238,"h_index":7,"latest_activity_year":2026,"source":"works"},"payments":{"company_count":2,"program_years":{"first":2021,"last":null},"rows_total":2,"shown":2,"withheld":0,"rows":[{"payer":"GE HEALTHCARE","program_year":2025,"amount_usd":51.66,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1558867374"},{"payer":"AstraZeneca Pharmaceuticals LP","program_year":2021,"amount_usd":112.95,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1558867374"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1558867374","source":"payments"},"prescribing":{"data_year":2021,"areas_total":2,"areas_shown":2,"areas":[{"area":"Cancer & immunology","share_pct":57.9,"classes_total":1,"classes":[{"class":"Androgen Receptor Inhibitor","setting":"prescribed","share_pct":57.9,"drugs":[{"name":"Xtandi","share_pct":100}],"max_beneficiaries":null}]},{"area":"Genitourinary & hormones","share_pct":42.1,"classes_total":1,"classes":[{"class":"alpha-Adrenergic Blocker","setting":"prescribed","share_pct":42.1,"drugs":[{"name":"Tamsulosin Hcl","share_pct":100}],"max_beneficiaries":null}]}],"source":"medicare"},"publications":{"total":38,"shown":5,"withheld":33,"matched_by":"OpenAlex author record","recent":[{"title":"ID #1002 Hematologic Toxicity during Proton Radiation: a Review of Weekly CBC Results at a Single Center","year":2026,"journal":"Neuro-Oncology Pediatrics","source_url":"https://doi.org/10.1093/neuped/wuag026.440","status":"verified"},{"title":"ID #761 Feasibility study of hypofractionated radiotherapy in the setting of recurrent diffuse intrinsic pontine glioma","year":2026,"journal":"Neuro-Oncology Pediatrics","source_url":"https://doi.org/10.1093/neuped/wuag026.320","status":"verified"},{"title":"An Exploratory Analysis of the Association Between Progesterone Use and Tumor-related Visual Deficit in Women With Meningioma","year":2026,"journal":"International Journal of Radiation Oncology*Biology*Physics","source_url":"https://doi.org/10.1016/j.ijrobp.2026.07.064","status":"verified"},{"title":"Geometric optimization of dose distribution in spatially fractionated radiation therapy","year":2025,"journal":"Physics in Medicine and Biology","source_url":"https://doi.org/10.1088/1361-6560/adf58f","status":"verified"},{"title":"Patient-reported outcomes after ipsilateral radiation therapy for N2b tonsillar squamous cell carcinoma","year":2025,"journal":"Discover Oncology","source_url":"https://doi.org/10.1007/s12672-025-03896-z","status":"verified"}],"source":"works"},"similar":[{"name":"Prasad Devarajan","slug":"prasad-devarajan","institution":"Cincinnati Children's Hospital Medical Center","specialty":"Pediatric Nephrology","url":"https://www.findmykol.com/kol/prasad-devarajan","json_url":"https://www.findmykol.com/kol/prasad-devarajan/profile.json"},{"name":"Stuart Goldstein","slug":"stuart-goldstein","institution":"Cincinnati Children's Hospital Medical Center","specialty":"Pediatric Nephrology","url":"https://www.findmykol.com/kol/stuart-goldstein","json_url":"https://www.findmykol.com/kol/stuart-goldstein/profile.json"},{"name":"Andrea Beaton","slug":"andrea-beaton","institution":"Cincinnati Children's Hospital Medical Center","specialty":"Pediatric Cardiology","url":"https://www.findmykol.com/kol/andrea-beaton","json_url":"https://www.findmykol.com/kol/andrea-beaton/profile.json"},{"name":"Andrew Redington","slug":"andrew-redington","institution":"Cincinnati Children's Hospital Medical Center","specialty":"Pediatric Cardiology","url":"https://www.findmykol.com/kol/andrew-redington","json_url":"https://www.findmykol.com/kol/andrew-redington/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":33}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2021}},"methodology_url":"https://www.findmykol.com/about#methodology"}